FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
-7.59%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(-16%)
Cap. Flow
-$13.1M
Cap. Flow
% of AUM
-10.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Lyell Immunopharma
LYEL
|
$5.21M |
| 2 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$1.53M |
Top Sells
| 1 |
Hims & Hers Health
HIMS
|
$19.8M |
Sector Composition
| 1 | Healthcare | 81.09% |
| 2 | Consumer Staples | 18.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1
Alumis Inc. Common Stock
ALMS
$479M
| $45.4M | 37.79% | 5,779,348 +194,459 | +3% | +$1.53M |
|
|
2
Hims & Hers Health
HIMS
$9.57B
| $22.7M | 18.91% | 939,860 -819,454 | -47% | -$19.8M |
|
3
CG Oncology
CGON
$2.04B
| $19.9M | 16.53% | 692,550 | – | – |
|
4
Disc Medicine
IRON
$2.07B
| $19M | 15.78% | 299,069 | – | – |
|
5
Cullinan Oncology
CGEM
$445M
| $8.01M | 6.67% | 657,905 | – | – |
|
|
6
Lyell Immunopharma
LYEL
$213M
| $5.21M | 4.33% | +8,133,047 | New | +$5.21M |
|